SCHEMBL6809818

SCHEMBL6809818

Cc1ccc(S(=O)(=O)OCCc2ccc(OCc3ccccc3)c(C(N)=O)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
LMNA P02545 3/20 0.46
MAPK1 P28482 1/20 0.46
RAB9A P51151 1/20 0.46
FFAR4 Q5NUL3 1/20 0.45
FOLH1 Q04609 1/20 0.44
KEAP1 Q14145 2/20 0.43
NFE2L2 Q16236 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PTGER1 P34995 1/20 0.43
PTGER4 P35408 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43
PARP1 P09874 1/20 0.43
HTT P42858 2/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10551303 0.80 POLB (0.54) MEN1KMT2ALMNARAB9AFFAR4
SCHEMBL6812542 0.80 MEN1 (0.43) MEN1KMT2AL3MBTL1SIRT2KDM4E
SCHEMBL9117894 0.78 HTR1A (0.52) LMNAMAPK1KEAP1NFE2L2L3MBTL1
SCHEMBL10983891 0.78 AR (0.58) FFAR4TDP1
SCHEMBL6812786 0.76 HTT (0.49) LMNAFFAR4FOLH1PARP1HTT
SCHEMBL6809852 0.76 FOLH1 (0.57) LMNAFFAR4FOLH1L3MBTL1PARP1
SCHEMBL241683 0.76 CA9 (0.54) LMNAL3MBTL1HTTSMN1; SMN2ALDH1A1
SCHEMBL18289526 0.74 CYP19A1 (0.50) MEN1KMT2AL3MBTL1CYP2C19
SCHEMBL6994087 0.74 LMNA (0.53) KMT2ALMNAPTGER1HTTMAPT
SCHEMBL6267075 0.73 KMT2A (0.53) MEN1KMT2ALMNAMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095932-B1 PHENOXYACETIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME KISSEI PHARMACEUTICAL (JP) 2004-05-19 EP disclosed
US-6538152-B1 Obesity, hyperglycemia, urinary incontinence, intestinal or biliary calculi hypermotility, pollakiuria and depression treatment KISSEI PHARMACEUTICAL CO., LTD. (JP) 2003-03-25 US disclosed
EP-1095932-A1 PHENOXYACETIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Kissei Pharmaceutical Co., Ltd. (JP) 2001-05-02 EP disclosed